Nanoscope Therapeutics Partners with Uniphar for MOGENRY
Dallas, Texas, United States, and Dublin, Ireland, November 19, 2026 Nanoscope Therapeutics, Inc. has entered into an exclusive partnership...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 Clinical Trial Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Dallas, Texas, United States, and Dublin, Ireland, November 19, 2026 Nanoscope Therapeutics, Inc. has entered into an exclusive partnership...
BETHESDA, Md., August 6, 2026 Northwest Biotherapeutics announced that it has entered into a non-binding Memorandum of Understanding (MOU)...
SALT LAKE CITY, April 2, 2026 Co-Diagnostics, Inc. announced that its joint venture CoMira Diagnostics has received approval to...
